Assessing the value of drugs for rare conditions: Institute for Clinical and Economic Review to host orphan drug assessment and pricing summit

7 February 2017 - Discussion will be anchored by an ICER Briefing Paper evaluating the evidence on the comparative clinical effectiveness ...

Read more →

ICER convenes broad group of stakeholders to inform update to value assessment framework

4 October 2016 - On 30 September 2016, the Institute for Clinical and Economic Review convened a one-day meeting with over ...

Read more →